Institutional investors purchased a net $403.3 thousand shares of TARO during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 12.11% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 148.5 Thousand shares of Taro Pharmaceutical Indus...
CREDIT SUISSE AG Bought 18.0 Thousand shares of Taro Pharmaceutical Indus...